Human T cell activation after alloantigen stimulation using different allogeneic combinations of macrophages and T cells was also significantly inhibited in most cultures, based on reduced CD69 and CD25 expression when the macrophages had been pre-treated with hypoxic GBM-derived EVs (Supplementary Fig. 7). This evidence concerns the gene CD69 and glioblastoma.